Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma

Figure 5

(a) The 5-year progression-free survival rate of LUAD patients with high levels of cg12430567 was distinctly lower than that of those patients with low levels of cg12430567. (b, c) Kaplan–Meier plots of overall survival in patients with LUAD and with low and high levels of methylation sites.

(a)

(b)

(c)